Gastritis Chronic
6
1
2
4
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
0.0%
0 terminated out of 6 trials
100.0%
+13.5% vs benchmark
50%
3 trials in Phase 3/4
0%
0 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (6)
Association Between Microplastic Exposure and the Pathological Progression of Gastric Carcinogenesis
Clinical Trial to Evaluate the Efficacy and Safety of DA-5219 in Patients With Acute or Chronic Gastritis
To Develop Methods for the Rehabilitation of Chronic Gastroduodenal Pathology in Children.
Evaluation of Antral Biopsies Obtained in Normal Esophagogastroduodenoscopy
To Evaluate the Efficacy and Safety of DW1903 in Acute and Chronic Gastritis Patient
To Evaluate the Efficacy and Safety of DW-1401 in Acute and Chronic Gastritis Patients